Mental Health Award: Transforming early intervention for anxiety, depression and psychosis in young people

Funding for projects that robustly test the real-world effectiveness and assess implementation strategies of scalable transformative early interventions for anxiety, depression and psychosis in young people.

Overview 

Lead applicant career stage:
Administering organisation location:
Anywhere in the world (apart from mainland China)
Frequency:
One-off
Funding amount:

£200,000 for the Foundation Phase and £5 to £8 million for the Impact Phase

Funding duration:

12 months for the Foundation Phase and 5 years for the Impact Phase

Coapplicants:
Accepted

This award is structured in two phases: a Foundation Phase followed by an Impact Phase. 

Foundation Phase (open to applications week commencing 28 July 2025) 

This first phase of the funding call will provide teams with £200,000 to build their teams and develop their detailed proposal for their research study over 12 months. This research proposal must be for a definitive effectiveness study and assessment of strategies for implementation and scaling of a psychological and/or a social intervention. The proposal must capture multiple outcomes that are relevant to people with lived experience and implementing partners, including mental health outcomes, functional outcomes and full economic evaluation.   

Projects will be chosen for the Foundation Phase based on:

  • the existing evidence of efficacy for the intervention

  • potential for being taken to scale, with the cost of the intervention low enough to be sustainable in the proposed context

  • potential for sustainable partnerships between research teams and implementing partners

  • outline plans for real-world testing of the effectiveness and implementation of the intervention

Teams taking part in the Foundation Phase will be invited to be part of a learning network to participate and share learning in key areas relevant to developing, implementing and scaling psychological and/or social interventions. Wellcome will work closely with teams during this Foundation Phase as they develop their full research proposals. 

Impact Phase (open to applications February 2027)

In the second phase of the funding call, all teams from the Foundation Phase will be invited to apply for the Impact Phase.  We expect the award amount for the Impact Phase to be between £5 million and £8 million and the duration to be up to 5 years. The upper limits will be confirmed during the Foundation Phase.

Who can apply 

To apply for this award, teams must include both researchers and implementation partners. Implementation partners are key stakeholders that enable implementation and scaling of the intervention in the intended context. At least one implementation partner must be included as a coapplicant in the team.   

We require teams to provide a detailed explanation of the roles and responsibilities of all implementation partners in the project. Applicants must also clearly demonstrate their strategies and concrete actions for fostering and maintaining relationships with these partners throughout the project and in the development of their application.

 Implementation partners could include:

  • national or local government agencies
  • private sector providers
  • healthcare providers
  • education providers
  • non-government organisations
  • community groups
  • international organisations

This is not an exhaustive list and more than one implementation partner may be essential for your project.

The research must take place in the United Kingdom and/or low- and middle-income countries (LMICs) but the lead researcher can be based anywhere in the world (except mainland China).

We expect research teams to be diverse and interdisciplinary and may include expertise in (not an exhaustive list):

  • mental health
  • lived experience
  • statistics
  • research methodology
  • health economics
  • implementation science

Due to the size of the Impact Phase award, the lead applicant needs to be an experienced researcher. We are committed to ensuring the involvement and development of early-career researchers as part of these awards and will require at least one early career researcher be included as a coapplicant.

Teams must include either a lead applicant or a coapplicant based in each of the countries where the research will take place.

Is your research right for this call? 

Proposed research projects must:

  1. Identify a psychological and/or social intervention for the treatment of anxiety, depression and/or psychosis in young people that has proven to be effective in a controlled or well-supported research setting. Interventions can be delivered through any mode or method (for example, face-to-face, digital, individual or group) or in any setting (for example, school, community or healthcare service)
  2. Demonstrate how the Foundation Phase will be used to develop sustainable partnerships and enhance plans for real-world testing of the proposed intervention.
  3. Describe outline plans for testing the effectiveness and implementation of the intervention and completing a full economic evaluation for the intervention at the Impact Phase.

Interventions must:

  • Be a psychological and/or a social intervention. We define these terms broadly and will consider any intervention targeting improvements in a person’s mental health by changing their cognitions, emotions, or behaviours by influencing psychological processes and/or interventions targeting social connections or social determinants of mental health.
  • Focus on early intervention for anxiety, depression and/or psychosis.
  • Be targeted at young people. We will consider interventions focused on people aged between 10 and 30, however our priority is to support intervening as early as possible in this age group and we are particularly interested to fund projects with interventions targeted at people under 18. We are including a larger age range to account for the later onset of psychosis and recognising that there are often delays in identifying and diagnosing mental health problems, particularly in LMICs.
  • Have one or more clear active ingredients identified for how the main components of the intervention produce a therapeutic effect. This builds on Wellcome’s active ingredients commission for youth anxiety and depression.
  • Have existing robust evidence for efficacy in the same broad age group, the same condition and the same mode of delivery that is being proposed for this funding call.
  • Have an outlined pathway to implementation at scale with the cost of the intervention low enough to be scalable and sustainable in the proposed context. 

Involvement of people with lived experience 

Lived experience experts must be engaged in multiple aspects and stages of the research. They should be involved as colleagues who use their personal knowledge and expertise to inform the strategic direction, governance, design and delivery of the research.

Application process timeline 

You must submit your application by 15:00 GMT on the deadline day. We don’t accept late applications.

  1. Week commencing 28 July 2025

    Full details of the call published and call opens to applications

  2. 3 September 2025

    Information webinar

    Time to be confirmed

  3. 11 November 2025

    Foundation Phase application deadline

  4. January 2026

    Foundation Phase shortlisting

  5. March 2026

    Foundation Phase interview committee

  6. March 2026

    Foundation Phase funding decision

  7. February 2027

    Impact Phase opens to applications

    All who took part in the Foundation Phase will be invited to apply to the Impact Phase.

  8. May 2027

    Impact Phase application deadline